US3221740A - Injection device - Google Patents

Injection device Download PDF

Info

Publication number
US3221740A
US3221740A US220776A US22077662A US3221740A US 3221740 A US3221740 A US 3221740A US 220776 A US220776 A US 220776A US 22077662 A US22077662 A US 22077662A US 3221740 A US3221740 A US 3221740A
Authority
US
United States
Prior art keywords
injection
column
skin
holder
units
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US220776A
Inventor
Rosenthal Sol Roy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US220776A priority Critical patent/US3221740A/en
Application granted granted Critical
Publication of US3221740A publication Critical patent/US3221740A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/20Surgical instruments, devices or methods, e.g. tourniquets for vaccinating or cleaning the skin previous to the vaccination
    • A61B17/205Vaccinating by means of needles or other puncturing devices

Definitions

  • This invention relates to a new and improved injection device for skin testing, vaccination, inoculation, and the like. More particularly, the invention relates to a device for making successive injections.
  • an injection device by which skin tests, vaccinations, or inoculations are made by employing a multiple puncture technique.
  • a biological test substance, a vaccine, or the like is introduced into the skin transcutaneously by multiple punctures of identical character and depth distributed over an area of the skin.
  • the device disclosed in the patent includes a thin metal plate or disc having needle-like projections punched therefrom and extending in parallel relationship from one side thereof, outwardly beyond the level of the adjacent surfaces of the plate.
  • the plate as shown in the patent, is provided with a pair of arms extending from opposite sides thereof which may serves as handles or finger pressure points during the use of the device.
  • the device After cleansing the skin and applying a quantity of test substance or vaccine thereto, the device is placed against the skin and pressed inwardly, thereby forming a plurality of skin punctures with a resulting injection of the substance at the site of each puncture, without scarification of the skin.
  • an improved injection device which includes interalia a rigid backing member of moldable plastic material adapted to be held in the fingers, a thin metal plate secured to the backing member, and a plurality of needle-like projections punched from the metal plate and projecting from one side thereof.
  • a prepared package is provided, wherein a dried biological substance is present on the needle-like projections for transcutaneous introduction into the body, and a substantially rigid, imperforate protective cover is removably secured to the backing member and covers the metal plate for protecting the needle-like projections and the biological substance thereon from contamination prior to use.
  • a transcutaneous injection device which includes a skin perforating member having a plurality of needle-like projections extending from one side thereof outwardly beyond the level of the outermost adjacent surface on the device.
  • a knob is secured to the perforating member and extends from the opposite side thereof. The knob is adapted to be held with one hand to press the perforating member against the skin, whereupon the needle-like projections puncture the skin at a plurality of points for the purpose of introducing biological substances into the body.
  • the injection device can be grasped .at any aspect of its perimeter, and then applied quickly and accurately and with improved visibilty during the injection.
  • the ease and rapidity of injection which is afforded enables the physician to vaccinate or treat large groups of patients within relatively short periods of time.
  • the foregoing injection devices have proven to be admirably suited for the intended purposes.
  • the latter injection device which includes a knob or thimble secured to a skin perforating member, is becoming increasingly popular owing to the additional advantages thereof.
  • enabling disposal of the device after it has been used once there are important applications or potential applications of the device where it is necessary or desirable to reduce the cost still further.
  • a new injection device includes a holder, a skin perforating member, and means for detachably securing the perforating member on the holder.
  • An injection may be made by grasping the holder and pressing the perforating member against the skin, and thereafter the perforating member may be removed from the holder and replaced by another like perforating member.
  • the holder may be reused while the skin perforating members are discarded.
  • a package containing a number of skin perforating members, which may be removed one at a time by the holder for a series of injections.
  • An important object of the present invention is to provide another low cost injection device for use where cost is a factor, such as in mass testing of patients or in multiple tests conducted on individuals.
  • An accompanying important object is to provide an injection device which maintains the necessary sanitary conditions and which preserves the purity of biological substances being injected.
  • an object of the invention is to provide a device which is safeguarded against the transfer of body fluids from one person to another, thereby preventing the transmission of, e.g., infectious hepatitis.
  • the subtances are not inter mixed and the purity thereof is preserved for each injection.
  • Another important object is to provide a complete selfcontained injection device for making successive injections, with the same or different biological substances, and on one or more individuals.
  • a specific object is to provide a device which includes a column of superposed skin perforating members, for makink an injection, removing the outermost member, and repeating the operations with each member in the column until the last member is used.
  • FIGURE 1 is a broken side elevational view of one embodiment of the new injection device, enlarged from actual size for the purposes of illustration;
  • FIG. 2 is a vertical cross-sectional View thereof; with skin perforating members shown in elevation;
  • FIG. 3 is an axial cross-sectional view of one of the injection units employed in the device of FIG. 1, taken on line 33 of FIG. 4;
  • FIG. 4 is a bottom plan view of one of the injection units in the device of FIG. 1;
  • FIG. 5 is a further enlarged bottom perspective view of a skin perforating member as employed in the injection unit shown in the preceding views;
  • FIG. 6 is a top plan view of a modification of the injection unit shown in FIGS. 1-4;
  • FIG. 7 is a broken side elevational view enlarged from actual size, of another embodiment of the injection device, with a cover for the device broken away and in section to illustrate its relationship to the outermost injection unit, and also illustrating the provision of a fluent composition in the cover;
  • FIG. 8 is a cross-sectional view like FIG. 3 of an injection unit as employed in the device of FIG. 7;
  • FIG. 9 is a cross-sectional view of a modification of the unit of FIG. 8, including a modified skin perforating memher;
  • FIG. 10 is a further enlarged top perspective view of the skin perforating member employed in the modification of FIG. 9.
  • the new injection device for making successive injections comprises a column of superposed skin perforating members, each perforating member including injection needle means extending from one side thereof, and means for removably joining the perforating members together in the column with the needle means extending towards the base of the column.
  • An injection may be made by grasping the column and pressing the needle means of the outermost perforating member against the skin, the outermost perforating member may be removed from the column following the injection, and thereafter successive injections may be made in like manner with succeeding perforating members.
  • one embodiment of the new injection device for making successive injections is a transcutaneous injection device generally indicated by the number 10 in FIGS. 1 and 2.
  • the device includes a column of superposed injection units 12 surmounted by a holder 14.
  • the components of the device are detachably joined together in frictional interengagement.
  • each injection unit 12 includes a skin perforating member 18 and a backing member 20.
  • the perforating member includes a base 34 which preferably is a very thin circular flat disc or plate, having a central rectangular opening 36.
  • Four needlelike projections 22 are punched or struck out from the base and extend perpendicular from one side thereof, at the corners of the opening 36.
  • Each projection is triangular in configuration with a relatively small base, and each terminates at its free end in a sharp point.
  • the skin perforating member thus is a one-piece integral construction of the base 34 and the projections 22.
  • the presently preferred material of construction for the member is metal sheet material or the like. However, it is contemplated that other suitable materials may be employed, such as a rigid plastic material, which may be reinforced.
  • the backing member comprises a cup body, including a substantially cylindrical tubular side wall 24 and an integral substantially cylindrical tubular base 26 of reduced diameter.
  • a slightly flared rim 28 preferably is provided at the top of the wall 24 as shown in FIG. 3.
  • the bottom of the side wall is joined to the base 26 by an inwardly directed annular flange 30 forming a shoulder with the top of the base.
  • the base is closed by a bottom wall 32.
  • the backing member 20 is a substantially rigid imperforate body preferably constructed in one piece.
  • a preferred material of construction is plastic, e.g., a moldable thermoplastic resinous material such as polyethylene or other polyolefine, polystyrene and the like. However, other suitable materials may be employed, such as metal.
  • the backing member and the perforating member are united in the illustrative embodiment by a layer 33 of any suitable adhesive or cement, joining the bottom wall 32 of the backing member to the side of the skin perforating member base 34 opposite to that from which the projections 22 extend.
  • the backing member and the skin perforating member may be united in various other appropriate ways, such as by heating the backing member to cause it to stick to the perforating member, or to cause the base 34 to become embedded in the surface of the bottom wall 32. Another mode of attachment is illustrated by way of example in FIGS. 9 and 10 and is described subsequently. It is also contemplated that the backing and perforating members may be provided in an integral one-piece unit.
  • each injection unit 12 receives another like unit therein in nesting relation, as illustrated in FIGS. 1 and 2.
  • the base 26 of the backing member for one unit nests within the side Wall 24 of an adjoining unit on which it is superposed.
  • the perforating member 18 on the upper unit is received within and completely enclosed and protected by the backing member of the lower unit, preferably maintaining the projections 22 in spaced relation to and out of contact with the latter backing member.
  • the inside diameter of the backing member side wall 24 is substantially the same as the outside diameter of the backing member base 26, to provide a size-on-size fit of adjoining units. In this manner, a plurality of units are removably joined together in a column of superposed units in frictional interengagement, with the projections 22 extending towards the base of the column.
  • the cover 16 comprises a substantially rigid imperforate cup body, including a substantially cylindrical tubular side wall 17 and an integral bottom wall 19 providing a closed end.
  • the cover preferably is constructed of plastic, or it may be constructed of other materials, as described above for the backing member.
  • the cover receives the outermost injection unit 12a within its open end in nesting relation, to cover and protect the outermost perforating member 18.
  • the cover may be employed in like manner on any succeeding unit 12 or the holder 14.
  • the cover preferably is provided with a slightly flared rim like the rim 28 on the side wall 24 seen in FIG. 3.
  • the holder 14 is a substantially cylindrical body preferably constructed of plastic material of the type described above, or it may be constructed of other material, such as metal.
  • the holder may be solid or hollow. In either event, it preferably includes a concave outer end wall 40. It includes a base 42 of reduced diameter, which is received within the wall 24 of an injection unit and subsequently may be received within the wall 17 of the cover in nesting relation.
  • the injection device 10 is grasped with one or more fingers on the holder, and the holder is designed especially to facilitate the last one or several injections.
  • a skin perforating member 18 may be secured to the base 42 of the holder, in the same manner as for an injection unit 12.
  • the holder may constitute a tubular body as shown, which is disposable following the last injection therewith.
  • the holder has a side wall 44 which is elongated or extended as compared to the wall 24 of each unit, to enable the holder to be grasped by the fingers especially when the last injections are made with the device.
  • a reusable holder 14 may be employed, in which case no perforating member 18 is mounted on the base 42, and the holder preferably is solid to provide greater durability.
  • an injection device constituting a column of injection units 12 is supplied to the user, who inserts the holder in the upper most injection unit prior to performing a series of injections.
  • FIG. 6 illustrates a modified injection unit 12', in top plan view.
  • the unit is the same as that of the preceding views, with the addition of a pair of tabs 46 which are integral with the rim 28 of the backing member wall, the tabs being in diametrically opposed relation.
  • the tabs project outwardly from the backing member, and are adapted to facilitate manual removal of the unit from a column of units.
  • the tabs of the several units may be arranged in staggered relation along the column of units, so that each unit may be removed in turn by finger pressure on one or both tabs of the unit.
  • FIG. 7 An injection device 50 is illustrated in FIG. 7 which is made up of frustro-conical components in nesting relation, and in frictional engagement with each other.
  • the device includes a plurality of injection units 52, a holder 54, and a cover 56.
  • each unit 52 includes a skin perforating member 18 and a backing member 58.
  • the backing member is constructed preferably of plastic, and includes a frustro-conical side wall 60 and an integral circular bottom wall 62 at the small end thereof.
  • the perforating member is joined to the outer surface of the bottom wall by a layer 38 of adhesive or cement, or the parts may be joined by heating the plastic backing member to cause it to adhere to or enclose the base of the perforating member.
  • the cover 56 comprises a cup body which may be constructed similarly to the backing member 58.
  • the holder 54 may be provided with a skin perforating member 18 attached to the base thereof, in which case the holder may be constructed as a hollow disposable item.
  • a more durable solid construction may be provided, with the omission of the perforating member 18, to render the holder reusable.
  • FIGS. 9 and 10 illustrate a modified injection unit 52', which is constructed with a modified skin perforating member 18.
  • the skin perforating member includes a base 34 and integral needle-like projections 22 as in the preceding embodiment 18, and in addition, a pair of diametrically opposed upstanding wings or flanges 64 v which are integral with the margin of the base.
  • the perforating member 18 is mounted on the bottom wall 62 of the backing member 58 by inserting the Wings 64 through corresponding openings 66 and bending or clinching the wings, as illustrated in FIG. 9.
  • the backing member 58 may be softened, in the case of a thermoplastic substance, or a cement may be employed in the openings 66, to close and seal the openings around the wings.
  • the injection device of my present invention is employed for skin testing, vaccination, or innoculation in similar manner to my aforesaid prior devices.
  • the skin perforating member base 34 may be about 0.2 mm. in thickness, and the projections 22 have the same thickness.
  • the projections lie substantially on the circumference of a circle of lesser diameter than the base.
  • the diameter of the base preferably is a minimum of about 8 to 10 mm. when a fourneedle device is employed.
  • the projections are spaced preferably from 4 to 10 mm. apart, and are preferably disposed about 1.5 to 3.5 mm. inwardly from the periphery of the base.
  • the diameter of the base preferably does not exceed 10 mm, and the width of the margin between the projections 22 and the periphery of the base is about 1.5 to 2.5 mm.
  • the projections extend from the outer side of the base for a distance of about 2 to 2.5 mm.
  • an antigen, allergen, or chemotherapeutic agent may be applied on the skin, or it may be applied on the perforating member projections 22 for injection.
  • biological substances may be provided in dried or semi-dried form on the projections.
  • the device 10 or 50 may include a quantity of an adherent fluent biologically active composition 68 (FIG. 7) in any of the cup bodies provided by the respective backing members 20 and 58, and covers 16 and 56.
  • the combination injection device and package thus provided is especially useful for supplying active substances which deteriorate or lose their potency on drying. It also assists in retaining a coating of the active substance on the surfaces of the projections 22 up to the time of use.
  • the active substance may be provided in a liquid or semi-liquid composition, such as in glycerine, agar or pectin.
  • a liquid or semi-liquid composition such as in glycerine, agar or pectin.
  • the cavity of each backing member or cover preferably is filled substantially to the base 34 of the perforating member, so as to immerse the projections in the composition.
  • the injection device 10 or 50 is assembled and supplied to the user in the manner illustrated in FIGS. 1 and 7.
  • the perforating member projections 22 are uncoated, coated, or immersed in the fluid composition 68 in an adjacent injection unit or cover, as desired.
  • the respective injection units 12 and 52, holders 14 and 54, and covers 16 and 56 are secured together in frictional interengagement in a column of superposed components.
  • the user may be supplied with a separate holder 14 or 54 having no perforating member 18 thereon, for repeated use with a succession of columns of multiple injection units.
  • the cover 16 or 56 is removed, and the holder 14 or 54 is grasped by the user.
  • one or more fingers may grasp the column at the location of the injection units 12 or 52.
  • the projections 22 of the outermost injection unit such as indicated at 12a in FIG. 1, are placed against the skin and pressed inwardly to form a plurality of skin punctures with a resulting injection of the biological substance at the site of each puncture.
  • the outermost injection unit may be removed from the column and discarded following the injection, and thereafter successive injections may be made in like manner with succeeding units 12.
  • Projections such as the tabs 46 illustrated in FIG. 6 may be provided on the backing member of each unit, and they are engaged by the fingers to facilitate removal of a unit following injection.
  • Vaccines which may be injected with the device include, for example, the vaccines for whooping cough, polio, rabies, yellow fever, smallpox, B.C.G. for tuberculosis, and others.
  • Exemplary testing materials include coccidiodin, blastomycin, histoplasmimlepromin, and tuberculin, as well as allergens for foods and pollens.
  • Chemotherapeutic agents include, for example, the antibiotics penicillin and streptomycin, and other active compounds.
  • each column of units may be provided with a series of perforatmg members 18 having the same active substances on the projections, for making the same injection on a number of persons.
  • perforating members each having a different biologically active substance on the projections thereof may be arranged in the column in a predetermined sequence. In this manner, the physician may be provided with perforating members bearing different allergens, .for example, so that a predetermined pattern of injections may be made on the skin of one individual as is commonly done in testing for allergic reactions.
  • the backing members 20 and 58 interposed between the successive skin perforating members 18 provide effective barriers or shields and spacers which prevent blood or other body fluids from reaching the succeeding units, thus preventing transfer of infectious hepatitis, for example.
  • testing substances on the perforating members are prevented from reaching succeeding units.
  • the construction prevents the substances from reaching succeeding units and possibly interfering with subsequent tests.
  • the new injection device is simply, economically and reliably constructed and used.
  • the skin perforating members may be fabricated in quantity by precise methods and assembled with the backing members.
  • the injection device maintains the sterility of the perforating members while being well suited for rapid, accurate and highly effective use in performing a series of injections.
  • An injection device for making successive injections comprising, a column of superposed injection units, each said injection unit including a skin perforating portion and a substantially rigid backing portion, each said skin perforating portion including a plurality of needle-like projections extending from one side thereof and said backing portions including means for joining said units together in said column with all of said projections extending toward a first end of the column, a holder in said column, and means for removably joining said holder to said units adjacent the second end of said column, said holder being of a size easily to be gripped by the fingers and having an axial length greater than the axial length of each of said injection units, whereby an injection may be made by grasping said column and pressing against the skin said projections of the unit at said first end of said column, whereupon said last mentioned unit may be removed from said column, and thereafter successive injections may be made in like manner with succeeding units.
  • An injection device for making successive injections comprising a column of superposed injection units, said column being surmounted at one of its ends by a holder of a size to be easily gripped by the fingers and having an axial length greater than the axial length of each of said injection units, each injection unit including a skin perforating member and a substantially rigid backing member, said perforating member including a plurality of needle-like projections extending from one side thereof, said backing member comprising a cup body receiving the succeeding unit therein in nesting relation for removably joining said units together in said column with said projections extending towards the second end of the column, said backing member of the uppermost unit receiving said holder therein in nesting relation for removably joining the holder thereto, whereby an injection may be made by grasping said holder and pressing against the skin said projections of the unit at said second end of said column, whereupon said last mentioned unit may be removed from said column following the injection, and thereafter successive injections may be made in like manner with succeeding units.
  • An injection device for making successive injections comprising a column of superposed injection units, each injection unit including a skin perforating member and a backing member, said perforating member including a plurality of needle-like projections extending from one side thereof, said backing member comprising a cup body receiving the succeeding unit therein in nesting relation for removably joining said units together in said column with said projections extending toward a first end of the column, and a quantity of an adherent fluent biologically active composition in at least one of said cup bodies for coating said projections on the succeeding unit therewith, whereby an injection may be made by grasping said column and pressing against the skin said projections of the unit at said first end of said column, whereupon said last mentioned unit may be removed from said column following the injection, and thereafter successive injections may be made in like manner with succeeding units.

Description

Dec. 7, 1965 s. R. ROSENTHAL 3,221,740
INJECTION DEVICE Filed Aug. 51, 1962 F/GI FIG. 2-
IN VEN TOR. 50/ Roy Rosenfha/ United States Patent 3,221,740 INJECTION DEVICE Sol Roy Rosenthal, 230 E. Delaware Place Chicago 11, Ill. Filed Aug. 31, 1962, Ser. No. 220,776 6 Claims. (Cl. 128-253) This invention relates to a new and improved injection device for skin testing, vaccination, inoculation, and the like. More particularly, the invention relates to a device for making successive injections.
As disclosed in my US. Patent No. 2,619,962, I have heretofore provided an injection device by which skin tests, vaccinations, or inoculations are made by employing a multiple puncture technique. A biological test substance, a vaccine, or the like is introduced into the skin transcutaneously by multiple punctures of identical character and depth distributed over an area of the skin. The device disclosed in the patent includes a thin metal plate or disc having needle-like projections punched therefrom and extending in parallel relationship from one side thereof, outwardly beyond the level of the adjacent surfaces of the plate. The plate, as shown in the patent, is provided with a pair of arms extending from opposite sides thereof which may serves as handles or finger pressure points during the use of the device. After cleansing the skin and applying a quantity of test substance or vaccine thereto, the device is placed against the skin and pressed inwardly, thereby forming a plurality of skin punctures with a resulting injection of the substance at the site of each puncture, without scarification of the skin.
In my copending patent application, Serial No. 787,086, filed January 15, 1959, I have disclosed and claimed an improved injection device which includes interalia a rigid backing member of moldable plastic material adapted to be held in the fingers, a thin metal plate secured to the backing member, and a plurality of needle-like projections punched from the metal plate and projecting from one side thereof. Very advantageously, a prepared package is provided, wherein a dried biological substance is present on the needle-like projections for transcutaneous introduction into the body, and a substantially rigid, imperforate protective cover is removably secured to the backing member and covers the metal plate for protecting the needle-like projections and the biological substance thereon from contamination prior to use.
In my copending patent application, Serial No. 166,582, filed January 16, 1962, I have disclosed and claimed further improvements on my aforesaid injection devices. In particular, a transcutaneous injection device is provided which includes a skin perforating member having a plurality of needle-like projections extending from one side thereof outwardly beyond the level of the outermost adjacent surface on the device. A knob is secured to the perforating member and extends from the opposite side thereof. The knob is adapted to be held with one hand to press the perforating member against the skin, whereupon the needle-like projections puncture the skin at a plurality of points for the purpose of introducing biological substances into the body. The injection device can be grasped .at any aspect of its perimeter, and then applied quickly and accurately and with improved visibilty during the injection. The ease and rapidity of injection which is afforded enables the physician to vaccinate or treat large groups of patients within relatively short periods of time.
The foregoing injection devices have proven to be admirably suited for the intended purposes. The latter injection device, which includes a knob or thimble secured to a skin perforating member, is becoming increasingly popular owing to the additional advantages thereof. However, despite its relative simplicity and economy, enabling disposal of the device after it has been used once, there are important applications or potential applications of the device where it is necessary or desirable to reduce the cost still further.
In my copending application, Serial No. 182,220, filed March 26, 1962, I have disclosed and claimed additional improvements. A new injection device includes a holder, a skin perforating member, and means for detachably securing the perforating member on the holder. An injection may be made by grasping the holder and pressing the perforating member against the skin, and thereafter the perforating member may be removed from the holder and replaced by another like perforating member. In this 'manner, the holder may be reused while the skin perforating members are discarded. There is also provided a package containing a number of skin perforating members, which may be removed one at a time by the holder for a series of injections.
An important object of the present invention is to provide another low cost injection device for use where cost is a factor, such as in mass testing of patients or in multiple tests conducted on individuals.
An accompanying important object is to provide an injection device which maintains the necessary sanitary conditions and which preserves the purity of biological substances being injected.
More particularly, an object of the invention is to provide a device which is safeguarded against the transfer of body fluids from one person to another, thereby preventing the transmission of, e.g., infectious hepatitis. Similarly, when successive tests are made with a series of different biologcal subtances, the subtances are not inter mixed and the purity thereof is preserved for each injection.
Another important object is to provide a complete selfcontained injection device for making successive injections, with the same or different biological substances, and on one or more individuals.
A specific object is to provide a device which includes a column of superposed skin perforating members, for makink an injection, removing the outermost member, and repeating the operations with each member in the column until the last member is used.
These and other objects, advantages and functions of the invention will be apparent on reference to the specification and to the attached drawings illustrating preferred embodiments of the invention, in which like parts are identified by like reference symbols in each of the views, and in which:
FIGURE 1 is a broken side elevational view of one embodiment of the new injection device, enlarged from actual size for the purposes of illustration;
FIG. 2 is a vertical cross-sectional View thereof; with skin perforating members shown in elevation;
FIG. 3 is an axial cross-sectional view of one of the injection units employed in the device of FIG. 1, taken on line 33 of FIG. 4;
FIG. 4 is a bottom plan view of one of the injection units in the device of FIG. 1;
FIG. 5 is a further enlarged bottom perspective view of a skin perforating member as employed in the injection unit shown in the preceding views;
FIG. 6 is a top plan view of a modification of the injection unit shown in FIGS. 1-4;
FIG. 7 is a broken side elevational view enlarged from actual size, of another embodiment of the injection device, with a cover for the device broken away and in section to illustrate its relationship to the outermost injection unit, and also illustrating the provision of a fluent composition in the cover;
FIG. 8 is a cross-sectional view like FIG. 3 of an injection unit as employed in the device of FIG. 7;
FIG. 9 is a cross-sectional view of a modification of the unit of FIG. 8, including a modified skin perforating memher; and
FIG. 10 is a further enlarged top perspective view of the skin perforating member employed in the modification of FIG. 9.
The new injection device for making successive injections comprises a column of superposed skin perforating members, each perforating member including injection needle means extending from one side thereof, and means for removably joining the perforating members together in the column with the needle means extending towards the base of the column. An injection may be made by grasping the column and pressing the needle means of the outermost perforating member against the skin, the outermost perforating member may be removed from the column following the injection, and thereafter successive injections may be made in like manner with succeeding perforating members.
Referring to the drawings, one embodiment of the new injection device for making successive injections is a transcutaneous injection device generally indicated by the number 10 in FIGS. 1 and 2. The device includes a column of superposed injection units 12 surmounted by a holder 14. The outermost =or lowermost injection unit 12a is protected by a cover 16. The components of the device are detachably joined together in frictional interengagement.
Referring also to FIGS. 3-5, each injection unit 12 includes a skin perforating member 18 and a backing member 20. The perforating member includes a base 34 which preferably is a very thin circular flat disc or plate, having a central rectangular opening 36. Four needlelike projections 22 are punched or struck out from the base and extend perpendicular from one side thereof, at the corners of the opening 36. Each projection is triangular in configuration with a relatively small base, and each terminates at its free end in a sharp point. The skin perforating member thus is a one-piece integral construction of the base 34 and the projections 22. The presently preferred material of construction for the member is metal sheet material or the like. However, it is contemplated that other suitable materials may be employed, such as a rigid plastic material, which may be reinforced.
The backing member comprises a cup body, including a substantially cylindrical tubular side wall 24 and an integral substantially cylindrical tubular base 26 of reduced diameter. A slightly flared rim 28 preferably is provided at the top of the wall 24 as shown in FIG. 3. The bottom of the side wall is joined to the base 26 by an inwardly directed annular flange 30 forming a shoulder with the top of the base. The base is closed by a bottom wall 32.
The backing member 20 is a substantially rigid imperforate body preferably constructed in one piece. A preferred material of construction is plastic, e.g., a moldable thermoplastic resinous material such as polyethylene or other polyolefine, polystyrene and the like. However, other suitable materials may be employed, such as metal. The backing member and the perforating member are united in the illustrative embodiment by a layer 33 of any suitable adhesive or cement, joining the bottom wall 32 of the backing member to the side of the skin perforating member base 34 opposite to that from which the projections 22 extend. The backing member and the skin perforating member may be united in various other appropriate ways, such as by heating the backing member to cause it to stick to the perforating member, or to cause the base 34 to become embedded in the surface of the bottom wall 32. Another mode of attachment is illustrated by way of example in FIGS. 9 and 10 and is described subsequently. It is also contemplated that the backing and perforating members may be provided in an integral one-piece unit.
The backing member 20 of each injection unit 12 receives another like unit therein in nesting relation, as illustrated in FIGS. 1 and 2. The base 26 of the backing member for one unit nests within the side Wall 24 of an adjoining unit on which it is superposed. The perforating member 18 on the upper unit is received within and completely enclosed and protected by the backing member of the lower unit, preferably maintaining the projections 22 in spaced relation to and out of contact with the latter backing member. The inside diameter of the backing member side wall 24 is substantially the same as the outside diameter of the backing member base 26, to provide a size-on-size fit of adjoining units. In this manner, a plurality of units are removably joined together in a column of superposed units in frictional interengagement, with the projections 22 extending towards the base of the column.
Similarly, the cover 16 comprises a substantially rigid imperforate cup body, including a substantially cylindrical tubular side wall 17 and an integral bottom wall 19 providing a closed end. The cover preferably is constructed of plastic, or it may be constructed of other materials, as described above for the backing member. The cover receives the outermost injection unit 12a within its open end in nesting relation, to cover and protect the outermost perforating member 18. The cover may be employed in like manner on any succeeding unit 12 or the holder 14. The cover preferably is provided with a slightly flared rim like the rim 28 on the side wall 24 seen in FIG. 3.
The holder 14 is a substantially cylindrical body preferably constructed of plastic material of the type described above, or it may be constructed of other material, such as metal. The holder may be solid or hollow. In either event, it preferably includes a concave outer end wall 40. It includes a base 42 of reduced diameter, which is received within the wall 24 of an injection unit and subsequently may be received within the wall 17 of the cover in nesting relation. The injection device 10 is grasped with one or more fingers on the holder, and the holder is designed especially to facilitate the last one or several injections.
A skin perforating member 18 may be secured to the base 42 of the holder, in the same manner as for an injection unit 12. In such case, the holder may constitute a tubular body as shown, which is disposable following the last injection therewith. The holder has a side wall 44 which is elongated or extended as compared to the wall 24 of each unit, to enable the holder to be grasped by the fingers especially when the last injections are made with the device. Alternatively, a reusable holder 14 may be employed, in which case no perforating member 18 is mounted on the base 42, and the holder preferably is solid to provide greater durability. In this case, an injection device constituting a column of injection units 12 is supplied to the user, who inserts the holder in the upper most injection unit prior to performing a series of injections.
FIG. 6 illustrates a modified injection unit 12', in top plan view. The unit is the same as that of the preceding views, with the addition of a pair of tabs 46 which are integral with the rim 28 of the backing member wall, the tabs being in diametrically opposed relation. The tabs project outwardly from the backing member, and are adapted to facilitate manual removal of the unit from a column of units. The tabs of the several units may be arranged in staggered relation along the column of units, so that each unit may be removed in turn by finger pressure on one or both tabs of the unit.
An injection device 50 is illustrated in FIG. 7 which is made up of frustro-conical components in nesting relation, and in frictional engagement with each other. The device includes a plurality of injection units 52, a holder 54, and a cover 56. As illustrated in FIG. 8, each unit 52 includes a skin perforating member 18 and a backing member 58. The backing member is constructed preferably of plastic, and includes a frustro-conical side wall 60 and an integral circular bottom wall 62 at the small end thereof. As in the preceding embodiment, the perforating member is joined to the outer surface of the bottom wall by a layer 38 of adhesive or cement, or the parts may be joined by heating the plastic backing member to cause it to adhere to or enclose the base of the perforating member. The cover 56 comprises a cup body which may be constructed similarly to the backing member 58. As in the prior embodiment, the holder 54 may be provided with a skin perforating member 18 attached to the base thereof, in which case the holder may be constructed as a hollow disposable item. Alternatively, a more durable solid construction may be provided, with the omission of the perforating member 18, to render the holder reusable.
FIGS. 9 and 10 illustrate a modified injection unit 52', which is constructed with a modified skin perforating member 18. The skin perforating member includes a base 34 and integral needle-like projections 22 as in the preceding embodiment 18, and in addition, a pair of diametrically opposed upstanding wings or flanges 64 v which are integral with the margin of the base. The perforating member 18 is mounted on the bottom wall 62 of the backing member 58 by inserting the Wings 64 through corresponding openings 66 and bending or clinching the wings, as illustrated in FIG. 9. If desired, the backing member 58 may be softened, in the case of a thermoplastic substance, or a cement may be employed in the openings 66, to close and seal the openings around the wings.
The injection device of my present invention, as illustrated by the embodiments numbered 10 and 50 in FIGS. 1 and 7, is employed for skin testing, vaccination, or innoculation in similar manner to my aforesaid prior devices. For such applications, the skin perforating member base 34 may be about 0.2 mm. in thickness, and the projections 22 have the same thickness. The projections lie substantially on the circumference of a circle of lesser diameter than the base. The diameter of the base preferably is a minimum of about 8 to 10 mm. when a fourneedle device is employed. The projections are spaced preferably from 4 to 10 mm. apart, and are preferably disposed about 1.5 to 3.5 mm. inwardly from the periphery of the base. For use in tuberculin testing, the diameter of the base preferably does not exceed 10 mm, and the width of the margin between the projections 22 and the periphery of the base is about 1.5 to 2.5 mm. The projections extend from the outer side of the base for a distance of about 2 to 2.5 mm.
In making injections with the new device, an antigen, allergen, or chemotherapeutic agent may be applied on the skin, or it may be applied on the perforating member projections 22 for injection. In the latter case, such biological substances may be provided in dried or semi-dried form on the projections. In a further advantageous embodiment, the device 10 or 50 may include a quantity of an adherent fluent biologically active composition 68 (FIG. 7) in any of the cup bodies provided by the respective backing members 20 and 58, and covers 16 and 56. The combination injection device and package thus provided is especially useful for supplying active substances which deteriorate or lose their potency on drying. It also assists in retaining a coating of the active substance on the surfaces of the projections 22 up to the time of use. The active substance may be provided in a liquid or semi-liquid composition, such as in glycerine, agar or pectin. The cavity of each backing member or cover preferably is filled substantially to the base 34 of the perforating member, so as to immerse the projections in the composition.
The injection device 10 or 50 is assembled and supplied to the user in the manner illustrated in FIGS. 1 and 7. The perforating member projections 22 are uncoated, coated, or immersed in the fluid composition 68 in an adjacent injection unit or cover, as desired. The respective injection units 12 and 52, holders 14 and 54, and covers 16 and 56 are secured together in frictional interengagement in a column of superposed components. Alternatively, the user may be supplied with a separate holder 14 or 54 having no perforating member 18 thereon, for repeated use with a succession of columns of multiple injection units.
With the injection device 10 or 50 assembled as illustrated, the cover 16 or 56 is removed, and the holder 14 or 54 is grasped by the user. Initially, one or more fingers may grasp the column at the location of the injection units 12 or 52. The projections 22 of the outermost injection unit, such as indicated at 12a in FIG. 1, are placed against the skin and pressed inwardly to form a plurality of skin punctures with a resulting injection of the biological substance at the site of each puncture. The outermost injection unit may be removed from the column and discarded following the injection, and thereafter successive injections may be made in like manner with succeeding units 12. Projections such as the tabs 46 illustrated in FIG. 6 may be provided on the backing member of each unit, and they are engaged by the fingers to facilitate removal of a unit following injection. Successive injections are made rapidly and reliably until the injection units in the column have been consumed, the last injection being made with the holder 14 or 54 where it is of the disposable type provided with a perforating member 18. In the case of a reusable holder, the holder is engaged with the uppermost injection unit of a new column of units, and injections are continued therewith. When injections are discontinued before an injection device is consumed, the cover 16 or 56 may be placed over the outermost remaining unused injection unit in the manner illustrated, to protect the unit during the interval between injections.
In this manner, a great variety of transcutaneous injections may be made with biologically active substances, including various antigens, allergens, and chemotherapeutic agents. Vaccines which may be injected with the device include, for example, the vaccines for whooping cough, polio, rabies, yellow fever, smallpox, B.C.G. for tuberculosis, and others. Exemplary testing materials include coccidiodin, blastomycin, histoplasmimlepromin, and tuberculin, as well as allergens for foods and pollens. Chemotherapeutic agents include, for example, the antibiotics penicillin and streptomycin, and other active compounds.
Where biologically active substances are provided on the projections 22 in the injection devices 10 and 50, each column of units may be provided with a series of perforatmg members 18 having the same active substances on the projections, for making the same injection on a number of persons. In another very useful application, perforating members each having a different biologically active substance on the projections thereof may be arranged in the column in a predetermined sequence. In this manner, the physician may be provided with perforating members bearing different allergens, .for example, so that a predetermined pattern of injections may be made on the skin of one individual as is commonly done in testing for allergic reactions.
The backing members 20 and 58 interposed between the successive skin perforating members 18 provide effective barriers or shields and spacers which prevent blood or other body fluids from reaching the succeeding units, thus preventing transfer of infectious hepatitis, for example. In like manner, testing substances on the perforating members are prevented from reaching succeeding units. When the perforating members are employed with different testing substances, the construction prevents the substances from reaching succeeding units and possibly interfering with subsequent tests.
The new injection device is simply, economically and reliably constructed and used. The skin perforating members may be fabricated in quantity by precise methods and assembled with the backing members. The injection device maintains the sterility of the perforating members while being well suited for rapid, accurate and highly effective use in performing a series of injections.
It will be apparent that various changes and modifications may be made in the construction and arrangement of the components of the new injection device within the spirit and scope of the invention, and it is intended that such changes and modifications be included within the scope of the appended claims.
I claim:
1. An injection device for making successive injections comprising, a column of superposed injection units, each said injection unit including a skin perforating portion and a substantially rigid backing portion, each said skin perforating portion including a plurality of needle-like projections extending from one side thereof and said backing portions including means for joining said units together in said column with all of said projections extending toward a first end of the column, a holder in said column, and means for removably joining said holder to said units adjacent the second end of said column, said holder being of a size easily to be gripped by the fingers and having an axial length greater than the axial length of each of said injection units, whereby an injection may be made by grasping said column and pressing against the skin said projections of the unit at said first end of said column, whereupon said last mentioned unit may be removed from said column, and thereafter successive injections may be made in like manner with succeeding units.
2. An injection device as defined in claim 1 and including a skin perforating portion on the base of said holder.
3. An injection device for making successive injections comprising a column of superposed injection units, said column being surmounted at one of its ends by a holder of a size to be easily gripped by the fingers and having an axial length greater than the axial length of each of said injection units, each injection unit including a skin perforating member and a substantially rigid backing member, said perforating member including a plurality of needle-like projections extending from one side thereof, said backing member comprising a cup body receiving the succeeding unit therein in nesting relation for removably joining said units together in said column with said projections extending towards the second end of the column, said backing member of the uppermost unit receiving said holder therein in nesting relation for removably joining the holder thereto, whereby an injection may be made by grasping said holder and pressing against the skin said projections of the unit at said second end of said column, whereupon said last mentioned unit may be removed from said column following the injection, and thereafter successive injections may be made in like manner with succeeding units.
4. An injection device as defined in claim 3 and including a skin perforating member secured to the base of the holder.
5. An injection device as defined in claim 3 and including a cover comprising a cup body receiving therein in nesting relation that one of said units at said second end of said column, said cover also being adapted for receiving any succeeding unit therein in nesting relation.
6. An injection device for making successive injections comprising a column of superposed injection units, each injection unit including a skin perforating member and a backing member, said perforating member including a plurality of needle-like projections extending from one side thereof, said backing member comprising a cup body receiving the succeeding unit therein in nesting relation for removably joining said units together in said column with said projections extending toward a first end of the column, and a quantity of an adherent fluent biologically active composition in at least one of said cup bodies for coating said projections on the succeeding unit therewith, whereby an injection may be made by grasping said column and pressing against the skin said projections of the unit at said first end of said column, whereupon said last mentioned unit may be removed from said column following the injection, and thereafter successive injections may be made in like manner with succeeding units.
References Cited by the Examiner UNITED STATES PATENTS 1,010,320 11/1911 Ruehs 22097 2,117,469 5/1938 Woodyatt 20643 X 2,619,962 12/1952 Rosenthal 128253 2,801,633 9/1957 Ehrlich 1283l4 2,818,070 12/1957 Barry 128-253 XR 2,876,774 3/1959 Kravitz et al 128253 2,893,392 7/1959 Wagner et a1. 128253 2,953,142 9/ 1960 Clementson 20656 RICHARD A. GAUDET, Primary Examiner.
R. I. HOFFMAN, ROBERT E. MORGAN, Examiners.

Claims (1)

1. AN INJECTION DEVICE FOR MAKING SUCCESSIVE INJECTIONS COMPRISING, A COLUMN OF SUPERPOSED INJECTION UNITS, EACH SAID INJECTION UNIT INCLUDING A SKIN PERFORATING PORTION AND A SUBSTANTIALLY RIGID BACKING PORTION, EACH SAID SKIN PERFORATING PORTION INCLUDING A PLURALITY OF NEEDLE-LIKE PROJECTIONS EXTENDING FROM ONE SIDE THEREOF AND SAID BACKING PORTIONS INCLUDING MEANS FOR JOINING SAID UNITS TOGETHER IN SAID COLUYMN WITH ALL OF SAID PROJECTIONS EXTENDING TOWARD A FIRST END OF THE COLUMN, A HOLDER IN SAID COLUMN, AND MEANS FOR REMOVABLY JOINING SAID HOLDER TO SAID UNITS ADJACENT THE SECOND END OF SAID COLUMN, SAID HOLDER BEING OF A SIZE EASILY TO BE GRIPPED BY THE FINGERS AND HAVING AN AXIAL LENGTH GREATER THAN THE AXIAL LENGTH OF EACH OF SAID INJECTION UNITS, WHEREBY AN INJECTION MAY BE MADE BY GRASPING SAID COLUMN AND PRESSING AGAINST THE SKIN SAID PROJECTIONS OF UNIT AT SAID FIRST END OF SAID COLUMN, WHEREUPON SAID LAST MENTIONED UNIT NAY BE REMOVED FROM SAID COLUMN, AND THEREAFTER SUCCESSIVE INJECTIONS MAY BE MADE IN LIKE MANNER WITH SUCCEEDING UNITS.
US220776A 1962-08-31 1962-08-31 Injection device Expired - Lifetime US3221740A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US220776A US3221740A (en) 1962-08-31 1962-08-31 Injection device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US220776A US3221740A (en) 1962-08-31 1962-08-31 Injection device

Publications (1)

Publication Number Publication Date
US3221740A true US3221740A (en) 1965-12-07

Family

ID=22824925

Family Applications (1)

Application Number Title Priority Date Filing Date
US220776A Expired - Lifetime US3221740A (en) 1962-08-31 1962-08-31 Injection device

Country Status (1)

Country Link
US (1) US3221740A (en)

Cited By (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3678150A (en) * 1971-07-27 1972-07-18 American Cyanamid Co Process for improving the stability of ppd, qt and histoplasmin on tine applicators
US4109655A (en) * 1975-10-16 1978-08-29 Manufacture Francaise d'Armes et Cycles de Saint-Etienne Manufrance Multi-penetration vaccination apparatus
US4237906A (en) * 1978-12-06 1980-12-09 Havstad Harold R Antigen injection assembly
US4607632A (en) * 1984-04-30 1986-08-26 Aller-Screen, Inc. Skin testing device with funnel loading
US6334856B1 (en) 1998-06-10 2002-01-01 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
WO2002003906A2 (en) * 2000-06-29 2002-01-17 Nikolay Grigorjevich Lyapko Modular applicator for reflexotherapy
US20020082543A1 (en) * 2000-12-14 2002-06-27 Jung-Hwan Park Microneedle devices and production thereof
US20020128599A1 (en) * 2000-10-26 2002-09-12 Cormier Michel J.N. Transdermal drug delivery devices having coated microprotrusions
US20020138049A1 (en) * 1998-06-10 2002-09-26 Allen Mark G. Microneedle devices and methods of manufacture and use thereof
US20030095582A1 (en) * 2000-12-21 2003-05-22 Ackley Donald E. Microneedle array systems
US20030135167A1 (en) * 2001-09-19 2003-07-17 Gonnelli Robert R. Microneedles, microneedle arrays, and systems and methods relating to same
US20030135166A1 (en) * 2001-09-28 2003-07-17 Gonnelli Robert R. Switchable microneedle arrays and systems and methods relating to same
US20030135158A1 (en) * 2001-09-21 2003-07-17 Gonnelli Robert R. Gas pressure actuated microneedle arrays, and systems and methods relating to same
US20030135201A1 (en) * 2001-09-28 2003-07-17 Gonnelli Robert R. Microneedle with membrane
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US20030181936A1 (en) * 2001-12-20 2003-09-25 Trautman Joseph C. Skin-piercing microprojections having piercing depth control
US20030199810A1 (en) * 2001-11-30 2003-10-23 Trautman Joseph Creagan Methods and apparatuses for forming microprojection arrays
US20040062813A1 (en) * 2002-06-28 2004-04-01 Cormier Michel J. N. Transdermal drug delivery devices having coated microprotrusions
US20040096455A1 (en) * 2002-08-08 2004-05-20 Yuh-Fun Maa Transdermal vaccine delivery device having coated microprotrusions
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US20040236271A1 (en) * 1997-12-10 2004-11-25 Felix Theeuwes Device and method for enhancing transdermal agent flux
US20050031676A1 (en) * 2003-08-04 2005-02-10 Wong Patrick S.L. Method and device for enhancing transdermal agent flux
US20050049625A1 (en) * 2003-08-26 2005-03-03 Steven Shaya Device and method for intradermal cell implantation
US20050106227A1 (en) * 2003-10-28 2005-05-19 Samuel Zalipsky Delivery of polymer conjugates of therapeutic peptides and proteins via coated microprojections
US20050171567A1 (en) * 2004-01-29 2005-08-04 Dehart Damon H. Lancet and method of manufacturing the same
US20050197308A1 (en) * 2000-07-21 2005-09-08 Smithkline Beecham Biologicals S.A. Vaccines
US20050261632A1 (en) * 2004-05-18 2005-11-24 Bai Xu High-Aspect-Ratio Microdevices and Methods for Transdermal Delivery and Sampling of Active Substances
US20060030811A1 (en) * 2004-08-03 2006-02-09 Wong Patrick S Method and device for enhancing transdermal agent flux
US20060051403A1 (en) * 2004-09-08 2006-03-09 James Matriano Microprojection array with improved skin adhesion and compliance
US20060074377A1 (en) * 2001-04-20 2006-04-06 Cormier Michel J Microprojection array immunization patch and method
US20070060867A1 (en) * 2005-05-18 2007-03-15 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US20070083151A1 (en) * 2003-12-29 2007-04-12 Carter Chad J Medical devices and kits including same
US20070184096A1 (en) * 2005-12-28 2007-08-09 Alza Corporation Stable Therapeutic Formulations
US20070191761A1 (en) * 2004-02-23 2007-08-16 3M Innovative Properties Company Method of molding for microneedle arrays
US20080039805A1 (en) * 2004-06-10 2008-02-14 Frederickson Franklyn L Patch Application Device and Kit
US20080051695A1 (en) * 2005-05-18 2008-02-28 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US7344499B1 (en) 1998-06-10 2008-03-18 Georgia Tech Research Corporation Microneedle device for extraction and sensing of bodily fluids
US20080102192A1 (en) * 2004-11-18 2008-05-01 Johnson Peter R Masking Method for Coating a Microneedle Array
US20080214987A1 (en) * 2006-12-22 2008-09-04 Nanomed Devices, Inc. Microdevice And Method For Transdermal Delivery And Sampling Of Active Substances
US20080294116A1 (en) * 2005-11-18 2008-11-27 Wolter James T Coatable Compositions, Coatings Derived Therefrom and Microarrays Having Such Coatings
US20080319404A1 (en) * 2005-12-21 2008-12-25 Pekurovsky Mikhail L Microneedle Devices
US20090118698A1 (en) * 2000-12-20 2009-05-07 Edelgard Liebl Device and method for applying an active ingredient to the skin
US7556821B2 (en) 2004-05-13 2009-07-07 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
US7579013B2 (en) 2003-06-30 2009-08-25 Alza Corporation Formulations for coated microprojections containing non-volatile counterions
US7621395B2 (en) * 2005-06-28 2009-11-24 Unomedical A/S Packing for infusion set and method of applying an infusion set
US20100137829A1 (en) * 2007-02-02 2010-06-03 Nielsen Henrik Boeje Injection Gateway
US20100140125A1 (en) * 2007-02-02 2010-06-10 Orla Mathiasen Injection Site for Injecting Medication
US20100222743A1 (en) * 2005-06-27 2010-09-02 Frederickson Franklyn L Microneedle array applicator device and method of array application
US7985199B2 (en) 2005-03-17 2011-07-26 Unomedical A/S Gateway system
US8012126B2 (en) 2006-10-31 2011-09-06 Unomedical A/S Infusion set
US8057842B2 (en) 2004-11-18 2011-11-15 3M Innovative Properties Company Method of contact coating a microneedle array
US8062250B2 (en) 2004-08-10 2011-11-22 Unomedical A/S Cannula device
US8221355B2 (en) 2004-03-26 2012-07-17 Unomedical A/S Injection device for infusion set
US8246588B2 (en) 2007-07-18 2012-08-21 Unomedical A/S Insertion device with pivoting action
US8267889B2 (en) 2004-11-18 2012-09-18 3M Innovative Properties Company Low-profile microneedle array applicator
US8303549B2 (en) 2005-12-23 2012-11-06 Unomedical A/S Injection device
US8414959B2 (en) 2004-11-18 2013-04-09 3M Innovative Properties Company Method of contact coating a microneedle array
US8430850B2 (en) 2007-07-03 2013-04-30 Unomedical A/S Inserter having bistable equilibrium states
US8439838B2 (en) 2006-06-07 2013-05-14 Unomedical A/S Inserter for transcutaneous sensor
US8486003B2 (en) 2007-07-10 2013-07-16 Unomedical A/S Inserter having two springs
US8562567B2 (en) 2009-07-30 2013-10-22 Unomedical A/S Inserter device with horizontal moving part
US8790311B2 (en) 2006-06-09 2014-07-29 Unomedical A/S Mounting pad
US8900194B2 (en) 2002-07-19 2014-12-02 3M Innovative Properties Company Microneedle devices and microneedle delivery apparatus
US8945057B2 (en) 2006-08-02 2015-02-03 Unomedical A/S Cannula and delivery device
US8961477B2 (en) 2003-08-25 2015-02-24 3M Innovative Properties Company Delivery of immune response modifier compounds
US9119945B2 (en) 2006-04-20 2015-09-01 3M Innovative Properties Company Device for applying a microneedle array
US9174035B2 (en) 2004-11-18 2015-11-03 3M Innovative Properties Company Microneedle array applicator and retainer
US9186480B2 (en) 2007-06-20 2015-11-17 Unomedical A/S Apparatus for making a catheter
US9211379B2 (en) 2006-02-28 2015-12-15 Unomedical A/S Inserter for infusion part and infusion part provided with needle protector
US9254373B2 (en) 2008-12-22 2016-02-09 Unomedical A/S Medical device comprising adhesive pad
US9415159B2 (en) 2010-03-30 2016-08-16 Unomedical A/S Medical device
US9440051B2 (en) 2011-10-27 2016-09-13 Unomedical A/S Inserter for a multiplicity of subcutaneous parts
US9533092B2 (en) 2009-08-07 2017-01-03 Unomedical A/S Base part for a medication delivery device
US9566384B2 (en) 2008-02-20 2017-02-14 Unomedical A/S Insertion device with horizontally moving part
US9724127B2 (en) 2010-09-27 2017-08-08 Unomedical A/S Insertion system and insertion kit
US10035008B2 (en) 2005-04-07 2018-07-31 3M Innovative Properties Company System and method for tool feedback sensing
US10315021B2 (en) 2005-06-24 2019-06-11 3M Innovative Properties Company Collapsible patch and method of application
US10369277B2 (en) 2005-09-12 2019-08-06 Unomedical A/S Invisible needle
US10525246B2 (en) 2006-12-22 2020-01-07 Nanomed Skincare, Inc. Microdevice and method for transdermal delivery and sampling of active substances
US10898643B2 (en) 2008-02-13 2021-01-26 Unomedical A/S Sealing between a cannula part and a fluid path
US11020526B2 (en) 2010-10-04 2021-06-01 Unomedical A/S Sprinkler cannula
US11110261B2 (en) 2011-10-19 2021-09-07 Unomedical A/S Infusion tube system and method for manufacture
US11197689B2 (en) 2011-10-05 2021-12-14 Unomedical A/S Inserter for simultaneous insertion of multiple transcutaneous parts

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1010320A (en) * 1911-04-28 1911-11-28 Charles L Ruehs Sanitary-cup holder.
US2117469A (en) * 1933-04-28 1938-05-17 Rollin T Woodyatt Injection instrument
US2619962A (en) * 1948-02-19 1952-12-02 Res Foundation Vaccination appliance
US2801633A (en) * 1954-02-17 1957-08-06 Joseph C Ehrlich Lancets
US2818070A (en) * 1955-03-28 1957-12-31 Aaron W Barry Scarifying applicator
US2876774A (en) * 1952-11-15 1959-03-10 Kravitz Harvey Means and method for vaccinating
US2893392A (en) * 1958-01-08 1959-07-07 American Cyanamid Co Article of manufacture for intracutaneous injections
US2953142A (en) * 1956-04-26 1960-09-20 Clementson Lars Lipstick assembly

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1010320A (en) * 1911-04-28 1911-11-28 Charles L Ruehs Sanitary-cup holder.
US2117469A (en) * 1933-04-28 1938-05-17 Rollin T Woodyatt Injection instrument
US2619962A (en) * 1948-02-19 1952-12-02 Res Foundation Vaccination appliance
US2876774A (en) * 1952-11-15 1959-03-10 Kravitz Harvey Means and method for vaccinating
US2801633A (en) * 1954-02-17 1957-08-06 Joseph C Ehrlich Lancets
US2818070A (en) * 1955-03-28 1957-12-31 Aaron W Barry Scarifying applicator
US2953142A (en) * 1956-04-26 1960-09-20 Clementson Lars Lipstick assembly
US2893392A (en) * 1958-01-08 1959-07-07 American Cyanamid Co Article of manufacture for intracutaneous injections

Cited By (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3678150A (en) * 1971-07-27 1972-07-18 American Cyanamid Co Process for improving the stability of ppd, qt and histoplasmin on tine applicators
US4109655A (en) * 1975-10-16 1978-08-29 Manufacture Francaise d'Armes et Cycles de Saint-Etienne Manufrance Multi-penetration vaccination apparatus
US4237906A (en) * 1978-12-06 1980-12-09 Havstad Harold R Antigen injection assembly
US4607632A (en) * 1984-04-30 1986-08-26 Aller-Screen, Inc. Skin testing device with funnel loading
US20040236271A1 (en) * 1997-12-10 2004-11-25 Felix Theeuwes Device and method for enhancing transdermal agent flux
US6503231B1 (en) 1998-06-10 2003-01-07 Georgia Tech Research Corporation Microneedle device for transport of molecules across tissue
US6334856B1 (en) 1998-06-10 2002-01-01 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
US8708966B2 (en) * 1998-06-10 2014-04-29 Georgia Tech Research Corporation Microneedle devices and methods of manufacture and use thereof
US20020138049A1 (en) * 1998-06-10 2002-09-26 Allen Mark G. Microneedle devices and methods of manufacture and use thereof
US7344499B1 (en) 1998-06-10 2008-03-18 Georgia Tech Research Corporation Microneedle device for extraction and sensing of bodily fluids
US20070225676A1 (en) * 1999-06-04 2007-09-27 Prausnitz Mark R Microneedle drug delivery device
US6611707B1 (en) 1999-06-04 2003-08-26 Georgia Tech Research Corporation Microneedle drug delivery device
US7226439B2 (en) 1999-06-04 2007-06-05 Georgia Tech Research Corporation Microneedle drug delivery device
US8257324B2 (en) 1999-06-04 2012-09-04 Georgia Tech Research Corporation Microneedle drug delivery device
US6743211B1 (en) 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
WO2002003906A3 (en) * 2000-06-29 2002-10-17 Nikolay Grigorjevich Lyapko Modular applicator for reflexotherapy
WO2002003906A2 (en) * 2000-06-29 2002-01-17 Nikolay Grigorjevich Lyapko Modular applicator for reflexotherapy
US20050197308A1 (en) * 2000-07-21 2005-09-08 Smithkline Beecham Biologicals S.A. Vaccines
US7537795B2 (en) 2000-10-26 2009-05-26 Alza Corporation Transdermal drug delivery devices having coated microprotrusions
US20020128599A1 (en) * 2000-10-26 2002-09-12 Cormier Michel J.N. Transdermal drug delivery devices having coated microprotrusions
US9302903B2 (en) 2000-12-14 2016-04-05 Georgia Tech Research Corporation Microneedle devices and production thereof
US20020082543A1 (en) * 2000-12-14 2002-06-27 Jung-Hwan Park Microneedle devices and production thereof
US20090118698A1 (en) * 2000-12-20 2009-05-07 Edelgard Liebl Device and method for applying an active ingredient to the skin
US20030095582A1 (en) * 2000-12-21 2003-05-22 Ackley Donald E. Microneedle array systems
US7027478B2 (en) 2000-12-21 2006-04-11 Biovalve Technologies, Inc. Microneedle array systems
US20090143724A1 (en) * 2001-04-20 2009-06-04 Alza Corporation Microprojection Array Immunization Patch and Method
US20060074377A1 (en) * 2001-04-20 2006-04-06 Cormier Michel J Microprojection array immunization patch and method
US20030135167A1 (en) * 2001-09-19 2003-07-17 Gonnelli Robert R. Microneedles, microneedle arrays, and systems and methods relating to same
US8361037B2 (en) 2001-09-19 2013-01-29 Valeritas, Inc. Microneedles, microneedle arrays, and systems and methods relating to same
US8920375B2 (en) 2001-09-21 2014-12-30 Valeritas, Inc. Gas pressure actuated microneedle arrays, and systems and methods relating to same
US20030135158A1 (en) * 2001-09-21 2003-07-17 Gonnelli Robert R. Gas pressure actuated microneedle arrays, and systems and methods relating to same
US20030135166A1 (en) * 2001-09-28 2003-07-17 Gonnelli Robert R. Switchable microneedle arrays and systems and methods relating to same
US20050137536A1 (en) * 2001-09-28 2005-06-23 Gonnelli Robert R. Microneedle with membrane
US20090062752A1 (en) * 2001-09-28 2009-03-05 Gonnelli Robert R Switchcable microneedle arrays and systems and methods relating to same
US20030135201A1 (en) * 2001-09-28 2003-07-17 Gonnelli Robert R. Microneedle with membrane
US20030199810A1 (en) * 2001-11-30 2003-10-23 Trautman Joseph Creagan Methods and apparatuses for forming microprojection arrays
US20030181936A1 (en) * 2001-12-20 2003-09-25 Trautman Joseph C. Skin-piercing microprojections having piercing depth control
US20040062813A1 (en) * 2002-06-28 2004-04-01 Cormier Michel J. N. Transdermal drug delivery devices having coated microprotrusions
US8900194B2 (en) 2002-07-19 2014-12-02 3M Innovative Properties Company Microneedle devices and microneedle delivery apparatus
US20040096455A1 (en) * 2002-08-08 2004-05-20 Yuh-Fun Maa Transdermal vaccine delivery device having coated microprotrusions
US7579013B2 (en) 2003-06-30 2009-08-25 Alza Corporation Formulations for coated microprojections containing non-volatile counterions
US20050031676A1 (en) * 2003-08-04 2005-02-10 Wong Patrick S.L. Method and device for enhancing transdermal agent flux
US8961477B2 (en) 2003-08-25 2015-02-24 3M Innovative Properties Company Delivery of immune response modifier compounds
US20050049625A1 (en) * 2003-08-26 2005-03-03 Steven Shaya Device and method for intradermal cell implantation
US20050106227A1 (en) * 2003-10-28 2005-05-19 Samuel Zalipsky Delivery of polymer conjugates of therapeutic peptides and proteins via coated microprojections
US20070083151A1 (en) * 2003-12-29 2007-04-12 Carter Chad J Medical devices and kits including same
US20050171567A1 (en) * 2004-01-29 2005-08-04 Dehart Damon H. Lancet and method of manufacturing the same
US20070191761A1 (en) * 2004-02-23 2007-08-16 3M Innovative Properties Company Method of molding for microneedle arrays
US8287516B2 (en) 2004-03-26 2012-10-16 Unomedical A/S Infusion set
US8221355B2 (en) 2004-03-26 2012-07-17 Unomedical A/S Injection device for infusion set
US7556821B2 (en) 2004-05-13 2009-07-07 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
US8361022B2 (en) 2004-05-13 2013-01-29 Alza Corporation Apparatus for transdermal delivery of parathyroid hormone agents
US7591806B2 (en) 2004-05-18 2009-09-22 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US20050261632A1 (en) * 2004-05-18 2005-11-24 Bai Xu High-Aspect-Ratio Microdevices and Methods for Transdermal Delivery and Sampling of Active Substances
US20080039805A1 (en) * 2004-06-10 2008-02-14 Frederickson Franklyn L Patch Application Device and Kit
US20060030811A1 (en) * 2004-08-03 2006-02-09 Wong Patrick S Method and device for enhancing transdermal agent flux
US8062250B2 (en) 2004-08-10 2011-11-22 Unomedical A/S Cannula device
US20060051403A1 (en) * 2004-09-08 2006-03-09 James Matriano Microprojection array with improved skin adhesion and compliance
US7846488B2 (en) 2004-11-18 2010-12-07 3M Innovative Properties Company Masking method for coating a microneedle array
US8267889B2 (en) 2004-11-18 2012-09-18 3M Innovative Properties Company Low-profile microneedle array applicator
US8414959B2 (en) 2004-11-18 2013-04-09 3M Innovative Properties Company Method of contact coating a microneedle array
US9174035B2 (en) 2004-11-18 2015-11-03 3M Innovative Properties Company Microneedle array applicator and retainer
US8057842B2 (en) 2004-11-18 2011-11-15 3M Innovative Properties Company Method of contact coating a microneedle array
US8758298B2 (en) 2004-11-18 2014-06-24 3M Innovative Properties Company Low-profile microneedle array applicator
US20080102192A1 (en) * 2004-11-18 2008-05-01 Johnson Peter R Masking Method for Coating a Microneedle Array
US8741377B2 (en) 2004-11-18 2014-06-03 3M Innovative Properties Company Method of contact coating a microneedle array
US7985199B2 (en) 2005-03-17 2011-07-26 Unomedical A/S Gateway system
US10035008B2 (en) 2005-04-07 2018-07-31 3M Innovative Properties Company System and method for tool feedback sensing
US20080051695A1 (en) * 2005-05-18 2008-02-28 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US20070060867A1 (en) * 2005-05-18 2007-03-15 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US8048017B2 (en) 2005-05-18 2011-11-01 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US8043250B2 (en) 2005-05-18 2011-10-25 Nanomed Devices, Inc. High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US10315021B2 (en) 2005-06-24 2019-06-11 3M Innovative Properties Company Collapsible patch and method of application
US20100222743A1 (en) * 2005-06-27 2010-09-02 Frederickson Franklyn L Microneedle array applicator device and method of array application
US9789249B2 (en) 2005-06-27 2017-10-17 3M Innovative Properties Company Microneedle array applicator device and method of array application
US8784363B2 (en) 2005-06-27 2014-07-22 3M Innovative Properties Company Microneedle array applicator device and method of array application
US7621395B2 (en) * 2005-06-28 2009-11-24 Unomedical A/S Packing for infusion set and method of applying an infusion set
US10369277B2 (en) 2005-09-12 2019-08-06 Unomedical A/S Invisible needle
US8900180B2 (en) 2005-11-18 2014-12-02 3M Innovative Properties Company Coatable compositions, coatings derived therefrom and microarrays having such coatings
US20080294116A1 (en) * 2005-11-18 2008-11-27 Wolter James T Coatable Compositions, Coatings Derived Therefrom and Microarrays Having Such Coatings
US20080319404A1 (en) * 2005-12-21 2008-12-25 Pekurovsky Mikhail L Microneedle Devices
US8303549B2 (en) 2005-12-23 2012-11-06 Unomedical A/S Injection device
US9278173B2 (en) 2005-12-23 2016-03-08 Unomedical A/S Device for administration
US20070184096A1 (en) * 2005-12-28 2007-08-09 Alza Corporation Stable Therapeutic Formulations
US8632801B2 (en) 2005-12-28 2014-01-21 Alza Corporation Stable therapeutic formulations
US9211379B2 (en) 2006-02-28 2015-12-15 Unomedical A/S Inserter for infusion part and infusion part provided with needle protector
US9119945B2 (en) 2006-04-20 2015-09-01 3M Innovative Properties Company Device for applying a microneedle array
US8439838B2 (en) 2006-06-07 2013-05-14 Unomedical A/S Inserter for transcutaneous sensor
US8790311B2 (en) 2006-06-09 2014-07-29 Unomedical A/S Mounting pad
US8945057B2 (en) 2006-08-02 2015-02-03 Unomedical A/S Cannula and delivery device
US8012126B2 (en) 2006-10-31 2011-09-06 Unomedical A/S Infusion set
US10525246B2 (en) 2006-12-22 2020-01-07 Nanomed Skincare, Inc. Microdevice and method for transdermal delivery and sampling of active substances
US20080214987A1 (en) * 2006-12-22 2008-09-04 Nanomed Devices, Inc. Microdevice And Method For Transdermal Delivery And Sampling Of Active Substances
US20100140125A1 (en) * 2007-02-02 2010-06-10 Orla Mathiasen Injection Site for Injecting Medication
US20100137829A1 (en) * 2007-02-02 2010-06-03 Nielsen Henrik Boeje Injection Gateway
US9186480B2 (en) 2007-06-20 2015-11-17 Unomedical A/S Apparatus for making a catheter
US9320869B2 (en) 2007-06-20 2016-04-26 Unomedical A/S Apparatus for making a catheter
US8430850B2 (en) 2007-07-03 2013-04-30 Unomedical A/S Inserter having bistable equilibrium states
US8486003B2 (en) 2007-07-10 2013-07-16 Unomedical A/S Inserter having two springs
US8246588B2 (en) 2007-07-18 2012-08-21 Unomedical A/S Insertion device with pivoting action
US10898643B2 (en) 2008-02-13 2021-01-26 Unomedical A/S Sealing between a cannula part and a fluid path
US10376637B2 (en) 2008-02-20 2019-08-13 Unomedical A/S Insertion device with horizontally moving part
US9566384B2 (en) 2008-02-20 2017-02-14 Unomedical A/S Insertion device with horizontally moving part
US9254373B2 (en) 2008-12-22 2016-02-09 Unomedical A/S Medical device comprising adhesive pad
US8562567B2 (en) 2009-07-30 2013-10-22 Unomedical A/S Inserter device with horizontal moving part
US9533092B2 (en) 2009-08-07 2017-01-03 Unomedical A/S Base part for a medication delivery device
US9415159B2 (en) 2010-03-30 2016-08-16 Unomedical A/S Medical device
US11786653B2 (en) 2010-03-30 2023-10-17 Unomedical A/S Insertion device
US9724127B2 (en) 2010-09-27 2017-08-08 Unomedical A/S Insertion system and insertion kit
US11020526B2 (en) 2010-10-04 2021-06-01 Unomedical A/S Sprinkler cannula
US11197689B2 (en) 2011-10-05 2021-12-14 Unomedical A/S Inserter for simultaneous insertion of multiple transcutaneous parts
US11110261B2 (en) 2011-10-19 2021-09-07 Unomedical A/S Infusion tube system and method for manufacture
US11684767B2 (en) 2011-10-19 2023-06-27 Unomedical A/S Infusion tube system and method for manufacture
US9440051B2 (en) 2011-10-27 2016-09-13 Unomedical A/S Inserter for a multiplicity of subcutaneous parts

Similar Documents

Publication Publication Date Title
US3221740A (en) Injection device
US3221739A (en) Injection device
US2893392A (en) Article of manufacture for intracutaneous injections
US3596660A (en) Injection device
US3072122A (en) Package for transcutaneous injection
AU2002243289B2 (en) Liquid applicator with diametrically opposed wings
US3688764A (en) Intracutaneous injection system
EP0407063A1 (en) Tines structure of clinical applicator
US4453926A (en) Scarifier
US4737149A (en) Syringe needle shield
US2696212A (en) Hypodermic syringe
US4222392A (en) Allergy testing device with vented base
US5605160A (en) Allergy testing apparatus with variably spaced test testing sites
EP0502115A4 (en) Combination sterile pad support and lancet containing lancet disposal element
US3322121A (en) Skin-puncturing unit with a collapsible protective cover
US5190169A (en) Device and method for the safe securing and disposal of sharps from medical tools
US4304241A (en) Skin testing device
US6086275A (en) Clinical scrub brush device
WO2015111673A1 (en) Microneedle unit and microneedle assembly
NZ232968A (en) Syringe assembly with needle shield having tamper evidence features
US6206838B1 (en) Autoloader and skin testing system
US5647371A (en) Skin testing device loading method
WO2003032785A1 (en) Sealable and manipulable pre-filled disposable pipette
JPS61234873A (en) Needle protector
US5564565A (en) Disposable hypodermic needle receptacle